CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum

被引：8

作者：

Turgeon, David ^{[1
]}

Bakowsky, Volodko ^{[2
]}

Baldwin, Corisande ^{[3
]}

Cabral, David A. ^{[4
]}

Clements-Baker, Marie ^{[5
]}

Clifford, Alison ^{[6
]}

Tervaert, Jan Willem Cohen ^{[6
]}

Dehghan, Natasha ^{[3
]}

Ennis, Daniel ^{[3
]}

Famorca, Leilani ^{[7
]}

Fifi-Mah, Aurore ^{[8
]}

Girard, Louis-Philippe ^{[9
]}

Lefebvre, Frederic ^{[10
]}

Liang, Patrick ^{[11
]}

Makhzoum, Jean-Paul ^{[12
]}

Massicotte-Azarniouch, David ^{[13
,14
]}

Mendel, Arielle ^{[15
]}

Milman, Nataliya ^{[16
]}

Reich, Heather N. ^{[17
]}

Robinson, David B. ^{[18
]}

Ross, Carolyn ^{[12
]}

Rumsey, Dax G. ^{[19
]}

Soowamber, Medha ^{[1
]}

Towheed, Tanveer E. ^{[5
]}

Trudeau, Judith ^{[20
]}

Twilt, Marinka ^{[21
]}

Yacyshyn, Elaine ^{[6
]}

Yardimci, Gozde K. ^{[1
]}

Khalidi, Nader ^{[7
]}

Barra, Lillian ^{[22
]}

Pagnoux, Christian ^{[1
]}

机构：

[1] Univ Toronto, Mt Sinai Hosp, Div Rheumatol, Vasculitis Clin, Toronto, ON, Canada

[2] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Div Rheumatol, Halifax, NS, Canada

[3] Univ British Columbia, Div Rheumatol, Vancouver, BC, Canada

[4] Univ British Columbia, BC Childrens Hosp, Div Pediat Rheumatol, Vancouver, BC, Canada

[5] Queens Univ, Div Rheumatol, Kingston, ON, Canada

[6] Univ Alberta, Div Rheumatol, Edmonton, AB, Canada

[7] McMaster Univ, Div Rheumatol, Hamilton, ON, Canada

[8] Univ Calgary, Div Rheumatol, Calgary, AB, Canada

[9] Univ Calgary, Div Nephrol, Calgary, AB, Canada

[10] Univ Montreal, Ctr Hosp Univ Montreal, Div Rheumatol, Montreal, PQ, Canada

[11] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Div Rheumatol, Sherbrooke, PQ, Canada

[12] Univ Montreal, Hop Sacre Coeur Montreal, Div Internal Med, Montreal, PQ, Canada

[13] Univ Ottawa, Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada

[14] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[15] McGill Univ, Div Rheumatol, Hlth Ctr, Montreal, PQ, Canada

[16] Univ Ottawa, Ottawa Hosp, Div Rheumatol, Ottawa, ON, Canada

[17] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada

[18] Univ Manitoba, Div Rheumatol, Winnipeg, MB, Canada

[19] Univ Alberta, Dept Pediat, Div Pediat Rheumatol, Edmonton, AB, Canada

[20] Univ Laval, Div Rheumatol, CISSS Chaudiere Appalaches, Quebec City, PQ, Canada

[21] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Div Pediat Rheumatol, Calgary, AB, Canada

[22] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada

来源：

RHEUMATOLOGY | 2023年 / 62卷 / 08期

关键词：

ANCA; anti-neutrophil cytoplasm antibody-associated vasculitis; granulomatosis with polyangiitis; microscopic polyangiitis; glomerulonephritis; avacopan; ANCA-ASSOCIATED VASCULITIS; REMISSION INDUCTION; GLUCOCORTICOIDS; CYCLOPHOSPHAMIDE; MANAGEMENT; RITUXIMAB; MORTALITY; PROTECTS;

D O I：

10.1093/rheumatology/kead087

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of avacopan in AAV based on a review of newly available evidence. Methods An updated systematic literature review on avacopan (formerly, CCX168) using Medline, Embase, and the Cochrane Library was performed for publications up to September 2022. New recommendations were developed and categorized according to the EULAR grading levels, as done for previous CanVasc recommendations. A modified Delphi procedure and videoconferences were used to reach >= 80% consensus on the inclusion, wording and grading of each recommendation. Results Three new recommendations were developed. They focus on avacopan therapy indication and duration, as well as timely glucocorticoid tapering. Conclusion These 2022 addended recommendations provide rheumatologists, nephrologists and other specialists caring for patients with AAV with guidance for the use of avacopan, based on current evidence and consensus from Canadian experts.

引用

页码：2646 / 2651

页数：6

共 50 条

[21] ANTINEUTROPHIL CYTOPLASM ANTIBODY (ANCA) ASSOCIATED VASCULITIS
MACISAAC, AI
MORAN, JE
DAVIES, DJ
MURPHY, BF
GEORGIOU, T
NIALL, JF
CLINICAL NEPHROLOGY, 1990, 34 (01) : 5 - 8
[22] Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine
Novikov, Pavel I.
Bulanov, Nikolai M.
Zykova, Anastasiia S.
Moiseev, Sergey V.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (02)
[23] Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Morishita, Kimberly A.
Wagner-Weiner, Linda
Yen, Eric Y.
Sivaraman, Vidya
James, Karen E.
Gerstbacher, Dana
Szymanski, Ann M.
O'Neil, Kathleen M.
Cabral, David A.
ARTHRITIS CARE & RESEARCH, 2022, 74 (09) : 1550 - 1558
[24] Role of Avacopan on Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Sandino, Justo
Morales, Enrique
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
[25] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
Rich, Eric N.
Brown, Kevin K.
CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 447 - 454
[26] Complement in antineutrophil cytoplasmic antibody-associated vasculitis
Jun Yuan
Min Chen
Ming-Hui Zhao
Clinical and Experimental Nephrology, 2013, 17 : 642 - 645
[27] A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Macia, Manuel
Diaz-Encarnacion, Montserrat
Solans-Laque, Roser
Mallol, Elisenda Pomares
Castells, Alejandra Garcia
Escribano, Cristina
de Arellano, Antonio Ramirez
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (02) : 227 - 235
[28] Complement in antineutrophil cytoplasmic antibody-associated vasculitis
Yuan, Jun
Chen, Min
Zhao, Ming-Hui
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 642 - 645
[29] ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED PARANEOPLASTIC VASCULITIS
NAVARRO, JF
QUEREDA, C
RIVERA, M
NAVARRO, FJ
ORTUNO, J
POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (823) : 373 - 375
[30] Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Keller, Sarah F.
Miloslavsky, Eli M.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 91 - +

← 1 2 3 4 5 →